Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysferlin and muscular dystrophy.

K M Bushby

    Acta Neurologica Belgica
    |December 1, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Limb-girdle muscular dystrophy (LGMD) is a diverse muscle disorder. Research highlights the dysferlin gene

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel autosomal dominant distal myopathy with early respiratory failure: clinico-pathologic characteristics and exclusion of linkage to candidate genetic loci.

    Annals of neurology·2001
    Same author

    The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach.

    Neuromuscular disorders : NMD·2001
    Same author

    Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies.

    Neuromuscular disorders : NMD·2001
    Same author

    Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).

    Neuromuscular disorders : NMD·2000
    Same author

    Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis.

    Journal of medical genetics·2000
    Same author

    Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation.

    Neurology·2000
    Same journal

    A rare case of severe hypertension following unilateral iatrogenic glossopharyngeal nerve injury during tonsillectomy.

    Acta neurologica Belgica·2026
    Same journal

    Synergistic pain relief in cervical radiculopathy: A randomized trial of topical methylcobalamin gel with phonophoresis and Mulligan mobilization.

    Acta neurologica Belgica·2026
    Same journal

    Characterizing cranial tremors in a case of spinocerebellar ataxia type 12: a unique positional tremor.

    Acta neurologica Belgica·2026
    Same journal

    A case of coexistence of spinal intradural capillary hemangioma and craniocervical junction dural arteriovenous fistula.

    Acta neurologica Belgica·2026
    Same journal

    Comment on "Content quality and reliability of youtube exercise videos for parkinson's disease".

    Acta neurologica Belgica·2026
    Same journal

    A novel CHMP2B variant of uncertain significance in a patient with apathy, hyperorality, and mild language impairment.

    Acta neurologica Belgica·2026
    See all related articles

    Area of Science:

    • Neurology
    • Genetics
    • Molecular Biology

    Background:

    • Limb-girdle muscular dystrophies (LGMD) represent a complex group of inherited muscle-weakening disorders.
    • Numerous genetic factors contribute to the heterogeneity observed in LGMD.
    • The dysferlin gene is a significant focus due to its unique characteristics.

    Purpose of the Study:

    • To review current understanding of LGMD caused by dysferlin gene mutations.
    • To highlight the novel aspects of the dysferlin gene in muscular dystrophy.
    • To discuss the implications of a newly identified mouse model for dysferlin deficiency.

    Main Methods:

    • Literature review of studies on dysferlin gene and LGMD.
    • Analysis of genetic mutations associated with dysferlinopathies.

    Related Experiment Videos

  • Examination of phenotypic variability in affected individuals.
  • Review of data from the naturally occurring mouse model.

    • Main Results:

    • Dysferlin is the first identified C2 domain-containing protein implicated in muscular dystrophy.
    • Mutations in the dysferlin gene lead to a variable clinical phenotype.
    • A spontaneous mouse model of dysferlin deficiency offers new research avenues.

    Conclusions:

    • Understanding dysferlin gene mutations is crucial for diagnosing and potentially treating specific LGMD forms.
    • The identification of the dysferlin gene and its mouse model advances the study of muscular dystrophies.
    • Further research into dysferlin function and pathology is warranted.